Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity

Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25

Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine

The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination

Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer